Table 3.

Percent Change in Adherence to Medical and Radiation Oncology Colorectal Cancer Quality Indicators between 2006 and 2009

	2006 Cases		2009 Cases
Indicator	Adherence, %	n/Eligible Cases	Adherence, %	n/Eligible Cases	Change, %*	p Value†
Medical oncology indicators
Consideration of adjuvant chemotherapy (all stage)	94.8	400/422	94.8	416/439	0.0	1.000
Explanation for not considering for treatment (all stages)	95.5	21/22	73.9	17/23	–21.5	0.096
Consent for chemotherapy	69.2	213/308	72.2	241/334	3.0	0.433
Flow sheet for chemotherapy	86.7	267/308	90.4	302/334	3.7	0.174
Documentation of BSA	99.4	306/308	99.7	333/334	0.3	0.621
Documented planned adjuvant chemotherapy treatment dose	58.1	179/308	67.7	226/334	9.5	0.017
Planned dose and cycles acceptable for chemotherapy regimens (nonmetastatic)	66.7	70/105	82.8	111/134	16.2	0.004
Treated with accepted regimen of adjuvant chemotherapy (nonmetastatic)	83.3	155/186	98.5	195/198	15.2	<0.001
Adjuvant chemotherapy within 8 weeks (nonmetastatic)	67.7	126/186	62.1	123/198	–5.6	0.287
Accepted regimen of neoadjuvant chemotherapy (nonmetastatic rectal cancer)	31.3	10/32	49.1	27/55	17.8	0.121
Receipt of neoadjuvant chemotherapy within 8 weeks of diagnosis (nonmetastatic rectal cancer)	87.5	28/32	76.4	42/55	–11.1	0.263
Radiation oncology indicators for rectal cancer
Consideration of radiation therapy	100	51/51	97.2	70/72	–2.8	0.506
Consultation with radiation oncologist	92.2	47/51	98.6	69/70	6.4	0.160
Receipt of neoadjuvant radiation treatment	80.9	38/47	85.5	59/69	4.7	0.615
Receipt of adjuvant radiation treatment	21.3	10/47	14.5	10/69	–6.8	0.456
Accepted dosage of radiation treatment	70.2	33/47	87.0	60/69	16.7	0.033

^*Difference in percent adherence between 2009 and 2006.

^†Exact Pearson chi-square p values computed using Monte Carlo estimation.

BSA, body surface area.